You are here

Article Text

Article menu
Download PDFPDF
Correspondence
Concerns on glucocorticoid use for Japanese patients with established rheumatoid arthritis

https://doi.org/10.1136/annrheumdis-2017-212206

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests HO reports personal fees from Astellas, Ayumi, Daiichi, Sankyo, Eisai, Dainippon Sumitomo, Chugai Pharmaceutical, outside the submitted work. HO has received lecture fees from Mitsubishi Tanabe, Takeda, AbbVie, Chugai, BMS, Astellas, Ayumi, Daiichi-Sankyo, Eisai, Asahi Kasei and Dainippon Sumitomo.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles